Angiex Inc. is a privately held biotech company focused on exploiting newly discovered biological transport mechanisms to develop drugs with revolutionary power over cancer. Based in Cambridge, Mass., the company is developing a portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus of cells in the tumor environment, enhancing the efficacy and therapeutic margin of conventional ADCs.
Leadership & Board
Current Number of Employees10
Current LinkedIn Followers1,692
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$31M
Total Amount Raised$31M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$31M
Latest Funding Amount$31M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Angiex Inc had 10 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Angiex Inc had 1,692 followers as of October 5, 2026. The number of followers increased by 6 (0.36%) week-over-week.
1,692Latest Followers Count
6(0.36%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 17, 2025
Investment
$31.00M
―
Similar Companies
A snapshot of private companies similar to Angiex Inc, helping you discover and navigate related company profiles.